#HIV treatment

Bill Gates and President Biden laud PEPFAR—which has saved 25 million lives—and urge its reauthorization this year.

People with HIV who recently used marijuana were twice as likely to miss taking their meds.

The new injectable antiretroviral keeps HIV under control, but it still needs an equally long-acting partner.

HIV treatment has greatly improved over the past 36 years.

HIV treatment has come a long way, but there’s still room for innovation.

Take this quiz on milestones in effective antiretroviral therapy in the United States.

Switching from TAF to TDF may help people lose weight, but this must be balanced against the risk of kidney problems and bone loss.

People with suppressed HIV respond well to mRNA vaccines, but individuals with a low CD4 count may not be adequately protected.

In a blog post titled “Five Takeaways From the 2022 U.S. Conference on HIV/AIDS,” POZ contributing writer Mark S. King shares his thoughts

The trial enrolled more than 4,600 previously untreated people who entered the trial with a CD4 count above 500.

Long-acting injectable Sunlenca (lenacapavir) is indicated for heavily treatment-experienced people with limited treatment options.

However, a new CDC report finds that linkage to HIV care and treatment remained strong.